Ype P De Jong MD
Hepatology & Liver Transplantation
Assistant Professor, Medicine, Weill Cornell Medical College
Request appointment
1 Gustave L Levy PlFl 1069New York, NY 10029
Overview of Dr. De Jong
Dr. Ype De Jong is a gastroenterologist in New York, NY and is affiliated with New York-Presbyterian Hospital. He received his medical degree from University of Amsterdam Faculty of Medicine and has been in practice 23 years. He is one of 339 doctors at New York-Presbyterian Hospital who specialize in Gastroenterology. He has more than 50 publications and over 500 citings.
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Gastroenterology, 2006 - 2010- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2004 - 2006
University of Amsterdam Faculty of MedicineClass of 2003
Certifications & Licensure
NY State Medical License 2008 - 2027- NY State Medical License 2010 - 2027
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012-2014, 2016-2017
Publications & Presentations
PubMed
- 19 citationsEctopic clotting factor VIII expression and misfolding in hepatocytes as a cause for hepatocellular carcinoma.Audrey Kapelanski-Lamoureux, Zhouji Chen, Zu-Hua Gao, Ruishu Deng, Anthoula Lazaris
Molecular Therapy. 2022-12-07 - 28 citationsIL-15 blockade and rapamycin rescue multifactorial loss of factor VIII from AAV-transduced hepatocytes in hemophilia A mice.John S S Butterfield, Kentaro Yamada, Thais B Bertolini, Farooq Syed, Sandeep R P Kumar
Molecular Therapy. 2022-12-07 - 20 citationsHuman hepatocyte PNPLA3-148M exacerbates rapid non-alcoholic fatty liver disease development in chimeric mice.Mohammad Kabbani, Eleftherios Michailidis, Sandra Steensels, Clifton G Fulmer, Joseph M Luna
Cell Reports. 2022-09-13
Grant Support
- Elucidating the host and viral determinants of treatment response in chronic hepatitis BROCKEFELLER UNIVERSITY2026–2031
- Enhancing immune regulation in gene therapy for hemophiliaINDIANA UNIVERSITY INDIANAPOLIS2016–2029
- Modeling alcohol toxicity in human hepatocytesWEILL MEDICAL COLL OF CORNELL UNIV2019–2025
